Invest now
Syngene International share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹383.55(-0.17%)September 11, 2026 15:29:13 PM IST
- NSE
- BSE
- Vol : 416.58 K (NSE + BSE)Last 20 day avg : 632.72 K
Syngene International is trading -0.17% lower at Rs 383.55 as compared to its last closing price. Syngene International has been trading in the price range of 384.05 & 374.75. Syngene International has given -41.01% in this year & -4.19% in the last 5 days. Syngene International has TTM P/E ratio 79.96 as compared to the sector P/E of 43.46.There are 8 analysts who have initiated coverage on Syngene International. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -9.00 Crores in its last quarter.Listed peers of Syngene International include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in Syngene International was at 25.78% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Syngene International was at 11.82% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 13 Sep 2026, 02:46 PM IST
- BetaMedium volatility1.12Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.09The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.33Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-5.87The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Syngene International News
Syngene International Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,842.00 | -1.18 | 4,41,947.09 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,326.00 | -0.84 | 2,47,576.00 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,975.00 | 0.95 | 1,89,226.24 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,365.00 | -1.09 | 1,10,272.68 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,119.50 | 0.13 | 1,11,670.56 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allSyngene International Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-22 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-23 | Quarterly Results |
About the company Syngene International
- IndustryBiotechnology & Drugs
- ISININE398R01022
- BSE Code539268
- NSE CodeSYNGENE
Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The Company's services include discovery, development, manufacturing, SynVent Integrated Drug discovery, dedicated centers, and Center for Advanced Protein Studies (CAPS). Its discovery services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. It offers preclinical development, active pharmaceutical ingredient and drug product development for both small molecules and biologics. It has capabilities for current Good Manufacturing Practices (cGMP) manufacturing from benchtop volume to commercial scale. SynVent is its drug discovery platform for enabling fully integrated therapeutic drug discovery and development across small molecules, new modalities and biologics.
Syngene International Share Price FAQs
Syngene International is trading at 383.55 as on Fri Sep 11 2026 09:59:13. This is -0.17% lower as compared to its previous closing price of 384.20.
The market capitalization of Syngene International is 15398.56 Cr as on Fri Sep 11 2026 09:59:13.
The average broker rating on Syngene International is Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 2 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Syngene International is 678.00 whereas the 52 wk low is 375.50
Syngene International can be analyzed on the following key metrics -
- TTM P/E: 79.96
- Sector P/E: 43.46
- Dividend Yield: 0.33%
- D/E ratio: -
Syngene International reported a net profit of 316.70 Cr in 2026.
The Mutual Fund Shareholding was 25.78% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Syngene International QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.